# Oral Versus Intravenous Sedation for Ocular Procedures

> **NCT03246724** · PHASE4 · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 327 (actual)

## Conditions studied

- Surgery
- Sedation

## Interventions

- **DRUG:** Triazolam
- **DRUG:** Midazolam
- **DRUG:** Microcrystalline Cellulose
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT03246724
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-16
- **Primary completion:** 2019-11-30
- **Final completion:** 2019-11-30
- **Target enrollment:** 327 (ACTUAL)
- **Last updated:** 2020-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246724, "Oral Versus Intravenous Sedation for Ocular Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03246724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*